KORI ANDERSON: Open Payments
NPI 1902227630 · CORVALLIS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 32 payments from 11 companies in 2025. Trend: 2023 $1,708 · 2024 $2,581 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $166 |
| Intra-Sana Laboratories | 1 | $130 |
| Neurocrine BioSciences, Inc. | 1 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Supernus Pharmaceuticals, Inc. | 4 | $64 |
| Almatica Pharma LLC | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Tris Pharma Inc | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Lilly USA, LLC | 1 | $18 |
Products named: VRAYLAR, RELTONE 200 MG, INGREZZA, TRINTELLIX, Qelbree, LOREEV XR, CAPLYTA, Dyanavel XR.
Industry payments across OR — which companies pay providers there.
